APA (7th ed.) Citation

Liu, D. (2023). KNOCKOUT OF API5 WITH CRISPR/CAS9 CONTRIBUTES TO GEMICITABINE RESISTANCE IN PANCREATIC CANCER. https://doi.org/10.25593/open-fau-149

Chicago Style (17th ed.) Citation

Liu, Dongxue. KNOCKOUT OF API5 WITH CRISPR/CAS9 CONTRIBUTES TO GEMICITABINE RESISTANCE IN PANCREATIC CANCER. Erlangen ; Nürnberg, 2023. https://doi.org/10.25593/open-fau-149.

MLA (9th ed.) Citation

Liu, Dongxue. KNOCKOUT OF API5 WITH CRISPR/CAS9 CONTRIBUTES TO GEMICITABINE RESISTANCE IN PANCREATIC CANCER. 2023. https://doi.org/10.25593/open-fau-149.